Posted on Leave a comment

On The Pen Launches Redesigned GLP-1 News Website as Independent Media Platform Expands

Dave Knapp, founder and CEO of On The Pen announces a redesigned GLP-1 news website, expanding its independent coverage of obesity medicine, diabetes, metabolic health and the pharmaceutical industry. On The Pen has launched a redesigned OnThePen.com, strengthening its position as a destination for GLP-1 news, obesity medicine coverage and patient-centered reporting. The platform is […]

Posted on Leave a comment

Simple Life Science Ranks US Peptide Suppliers by Lot Documentation

Simple Life Science leads a 2026 list of US research peptide suppliers vetted on lot documentation, analytical characterization, and defined specifications. Independent review of laboratory peptide suppliers finds documentation depth, lot-level analytical characterization, and defined specification control displacing price as the primary purchasing criterion for institutional buyers in the United States in 2026. NEW YORK […]

Posted on Leave a comment

Nonalcoholic Steatohepatitis Market Set to Witness Growth with Expanding Late-Stage Pipeline by 2034 – DelveInsight | Novo Nordisk, Madrigal Pharmaceuticals, 89bio, Akero Therapeutics

The Key Nonalcoholic Steatohepatitis Companies in the market include – Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Eli Lilly and Company, Madrigal Pharmaceuticals, Inc, Terns, Inc., Intercept Pharmaceuticals, Enyo Pharma, 89bio, Inc., Akero Therapeutics, Inc, and others. (Albany, US), September 11, 2026 – DelveInsight’s report “Nonalcoholic Steatohepatitis Diagnostics Market Insights, Epidemiology, and Market Forecast-2034” provides […]

Posted on Leave a comment

Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2036 – DelveInsight | Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Lab, Amgen, Teva Pharma, Anne Lindblad

The Key Migraine Companies in the market include – Eli Lilly and Company, Teva Pharmaceuticals, Axsome Therapeutics, AEON Biopharma, Inc., Charleston Laboratories, Amgen, Teva Pharmaceuticals, Eli Lilly and Company, Anne Lindblad, Allergan, AbbVie, Tian Medical Inc., Allergan, H. Lundbeck A/S, Tonix Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., and others . The Migraine market is expected to […]

Posted on Leave a comment

Chronic Hepatitis B Market Statistics Expected to Experience Major Growth by 2034, According to DelveInsight | Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Precision Biosciences, Silverback Thera

The Key Chronic Hepatitis B Companies in the market include – Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Precision Biosciences, Silverback Therapeutics, GSK, Drug Farm, Arbutus bio, Dicerna Pharmaceuticals, Roche, Ligand Pharmaceuticals, Dong-A ST Co., Vir Biotechnology, Arbutus Biopharma, and others. (Albany, New York) – September 11, 2026: DelveInsight’s “Chronic Hepatitis B Market Insights, Epidemiology, and Market […]

Posted on Leave a comment

Motor Neuron Disease Clinical Trial Drug Development Pipeline Expands with Contributions from 180+ Key Companies | DelveInsight

The Motor Neuron Disease clinical trial analysis report delivers important insights into ongoing research on 180+ pipeline Motor Neuron Disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 10, 2026- DelveInsight’s, “Motor Neuron Disease Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Motor Neuron Disease […]

Posted on Leave a comment

Osteoarthritis Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Osteoarthritis Clinical Trial analysis report delivers important insights into ongoing research of 100+ pipeline Osteoarthritis drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, New York, USA) September 07, 2026- DelveInsight’s “Osteoarthritis Pipeline Insights 2026” report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the osteoarthritis pipeline landscape. It covers the […]

Posted on Leave a comment

Lactase Enzyme FAQ for Buyers: Specifications, Applications, and How to Choose a Reliable Supplier

Xi’an, Shaanxi, China – September 7, 2026 – Driven by the growing market for lactose-free food, lactase, as a key functional enzyme raw material, is widely used in dairy products, nutritional supplements and food processing. For procurement professionals, selecting the right lactase enzyme requires more than just checking enzyme activity. Factors including enzyme type, stability, intended-use […]

Posted on Leave a comment

Glioblastoma Multiforme Market is Projected to Reach USD 4,800 Million by 2036, Driven by Advancements in Immunotherapy, Targeted Therapies, and Novel Treatment Approaches | DelveInsight

DelveInsight’s latest report, “Glioblastoma Multiforme Market Insight, Epidemiology and Market Forecast – 2036,” provides a comprehensive analysis of the Glioblastoma Multiforme (GBM) market across the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. According to DelveInsight’s estimates, the Glioblastoma Multiforme market size in the 7MM was approximately USD 900 million […]

Posted on Leave a comment

Hemophilia B Market is Projected to Witness Significant Growth by 2036 Owing to Advancements in Gene Therapy and Expansion of Non-Factor Replacement Treatments | DelveInsight

The market dynamics for Hemophilia B are witnessing steady growth driven by advancements in diagnostic capabilities, increasing disease awareness, improved access to specialized care centers, and the growing adoption of prophylactic treatment. (Albany, New York)- 5th Sep 2026, The market dynamics for Hemophilia B are witnessing steady growth driven by advancements in diagnostic capabilities, increasing […]